Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

NCT05100069 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG: Brigatinib

Sponsor

Takeda